Launch
Website- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
Specialises in
- Breast
- Colon
- Gynaecology
- Lower GI
- Lung
- Soft tissue
- Urology
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Hiley is an Associate Professor with tenure in Radiation Oncology at UCL and a Consultant Clinical Oncologist at UCLH. He is the UK clinical director for lung cancer at GenesisCare.
He specialises in stereotactic radiotherapy (SBRT) for all kinds of metastatic cancers e.g. breast, prostate, colorectal, lung, sarcoma etc.
Dr Hiley specialises in all the non-surgical treatments for all types of lung cancer. He has expertise in chemotherapy, immunotherapy and radiotherapy including state of the art radiotherapy techniques including Volumetric Arc Therapy (VMAT), Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGRT), Proton Therapy and Stereotactic Radiotherapy (SBRT).
He graduated with honours from the University in Manchester in 2005. He has trained in Oncology at many centres of excellence both in the UK and aboard. These include the Christie Hospital, the MD Anderson Cancer Centre (Houston, USA), Kings College (NIHR Clinical Lecturer) and the Royal Marsden (NIHR Clinical Fellow). He completed a PhD at the University of London with the Barts Cancer Institute and a postdoctoral research Fellowship the Francis Crick Institute and the UCL Cancer institute.
He became a consultant in 2018 and is clinical lead of the clinical oncology lung team at UCLH, UCLH Lead for Lung Proton Therapy, Deputy Lead of Clinical Trials for the CRUK Lung Cancer Centre of Excellence and NIHR Clinical Research Network Speciality Research Lead Radiotherapy for North London. He heads a research group at the UCL Cancer Institute focused on understanding resistance to radiation therapy.
He is the principal investigator and national chief investigator for several academic and commercial clinical trials in lung cancer. He has published in several the world’s leading journals including NEJM, The Lancet, Nature and Cell. He is a member of the expert group which authored the Radiotherapy for Lung Cancer Royal College of Radiologists Consensus Statement.
Areas of interest
Non-small cell lung cancer, small cell lung cancer, mesothelioma, thymoma, stereotactic radiotherapy, IMRT, VMAT, SBRT, immunotherapy, chemotherapy, radiotherapy, oligometastatic disease
Medical secretaries
- Shamin Shariff
- Leaders in Oncology Care 95-97 Harley Street London W1G 6AF
- 020 7317 2526
- hiley.pa@healthcare.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
A1080
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (5-50)
GenesisCare, Cromwell Hospital (5-50) Harley Street Clinic (1-5) Cromwell Hospital (1-5) HCA - Leaders in Oncology Care (1-5)
-
20365
Follow-up out-patient consultation - remote - (5-50)
-
X6930
Clinical supervision of the planning of a course of complex radiotherapy - (5-50)
GenesisCare, Cromwell Hospital (5-50) Cromwell Hospital (1-5) HCA - Leaders in Oncology Care (1-5)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
HCA - Leaders in Oncology Care (1-5) Harley Street Clinic (1-5)
- Show All (11 )...